Paysign Announces Acquisition of Gamma Innovation’s Assets, Appoints Michael Ngo as CIO
Paysign, Inc. (NASDAQ: PAYS), a prominent provider of patient affordability solutions, financial technology products, and integrated payment processing services, has announced the acquisition of the assets of Gamma Innovation LLC (Gamma). This strategic acquisition significantly enhances Paysign’s technological capabilities in plasma donor engagement and pharmaceutical patient engagement solutions. Additionally, as part of this acquisition, Paysign has appointed Michael Ngo, the former Managing Member of Gamma, as its Chief Innovation Officer.
Strengthening Paysign’s Growth Strategy
The acquisition marks a significant milestone for Paysign as it advances its growth strategy and expands its portfolio of technology-driven solutions. “This acquisition represents an exciting milestone for Paysign as we accelerate our growth strategy and expand our technology-driven solutions,” said Mark Newcomer, President and CEO of Paysign. “Michael and his team have developed innovative donor engagement and management solutions for the blood and plasma collection industry. By integrating Gamma’s technologies, Paysign will deliver enhanced engagement, compensation, and resource management solutions across our core markets.”
Newcomer emphasized that these new capabilities will not only strengthen Paysign’s relationship with plasma clients but also enhance its patient affordability solutions. By incorporating advanced patient retention and adherence tools, the company aims to significantly improve patient engagement in the pharmaceutical industry. “We enthusiastically welcome Michael and his team, recognizing their substantial contributions as highly synergistic to Paysign’s long-term strategic vision,” Newcomer added.
Michael Ngo’s Vision for Innovation
Michael Ngo, the newly appointed Chief Innovation Officer at Paysign, expressed his excitement about joining the company. “We have long admired Paysign’s position as a trusted payments leader in the plasma industry, and it quickly became clear that our shared vision for integrating donor engagement, management, and compensation was perfectly aligned,” said Ngo. “We are eager to deploy our technology to enhance Paysign’s robust solutions for the blood and plasma collection industry and to expand the potential of Paysign’s rapidly growing patient affordability business.”
Key Assets Acquired
With this acquisition, Paysign gains access to several cutting-edge assets developed by Gamma, including:
- A Donor Engagement App: This mobile application is designed to reduce labor costs and donor fees while improving donor retention. The app seamlessly integrates with existing donor management systems, delivering immediate value to plasma centers without requiring complex implementations.
- A Specialized Customer Resource Management (CRM) Platform: Unlike traditional one-size-fits-all CRMs, this platform is tailored specifically for the blood and plasma collection industry. It reduces unnecessary expenses, improves donor engagement, enhances marketing effectiveness, and increases retention through customizable journey automation.
- Additional Donor Management Solutions: These innovative tools are designed to reduce operating costs, optimize donor compensation through intelligent payments, and enhance efficiency throughout the donation process.
- An Existing Contract with a Paysign Customer: This agreement involves the development of applications that support marketing and donor engagement initiatives.
The Talent Behind Gamma Innovation
Paysign has also welcomed a team of seasoned professionals from Gamma Innovation, each bringing valuable expertise to the company:
Michael Ngo – Chief Innovation Officer
A seasoned technologist and entrepreneur, Michael Ngo has over 25 years of experience in delivering innovative technology solutions across finance, pharmaceuticals, enterprise software, and digital media. Having led digital transformations and scaled technology ventures, Ngo has played a critical role in implementing technology initiatives that have driven multimillion-dollar growth. Throughout his career, he has developed over 30 mobile and web applications and has consulted for Global Fortune 1000 companies. His expertise spans software development, SaaS, digital media, and strategic consulting. Previously, he held executive roles at IBM and Citibank’s Software and Technology Services group, focusing on business development, operational efficiency, and software implementations.
Howard Steidle – Global Business Strategist
Howard Steidle is a seasoned global business strategist and entrepreneur with an MBA from The Wharton School of the University of Pennsylvania. With over a decade of international business experience in operations and cross-border B2B development, Steidle specializes in leveraging technology to optimize business logistics and digital marketing strategies to enhance customer engagement and retention. His deep understanding of the plasma industry has allowed him to provide strategic consulting to businesses navigating complex market landscapes and driving innovation.
Bei Xu – AI and Data Analytics Expert
Bei Xu is a recognized leader in AI-driven data analytics, boasting over 25 years of experience in data science, artificial intelligence (AI), and digital transformation. Xu has led large-scale AI and data initiatives for Fortune 500 corporations, enabling digital transformation, regulatory compliance, and operational efficiency. Her expertise in pharmaceutical operations, supply chain management, and regulatory reporting has helped global companies harness AI, cloud computing, and big data for strategic growth.
Sam Wang – Software Development Innovator
Sam Wang is a key driver behind intelligent platform development and accelerated software delivery. A seasoned software leader with over a decade of experience optimizing the software development life cycle (SDLC) through strategic automation and AI integration, Wang has recently developed innovations that have cut “go-to-market” timelines by 20-30%. Holding a Master’s Degree in Information Systems from Stevens Institute of Technology, Wang brings both strategic insight and hands-on technical expertise to Paysign.
Enhancing Paysign’s Competitive Edge
With this acquisition, Paysign is well-positioned to enhance its technological capabilities and expand its footprint in the plasma donor and pharmaceutical patient engagement sectors. The integration of Gamma’s technologies will allow Paysign to offer more advanced and efficient solutions, strengthening its market leadership.
By leveraging Gamma’s proprietary solutions and expertise, Paysign aims to optimize the donor and patient experience while driving cost efficiencies for plasma centers and pharmaceutical partners. The company’s focus on innovation will continue to be a driving force behind its mission to provide cutting-edge financial and patient affordability solutions.
